Perhaps not IBM but I wouldnt be surprised to see a TO/merger etc of SE1 with Nanodx tech/suppliers being consolidated to maximise profit for whoever backs the corporate action. Nanodx and all suppliers as a SPAC (once fda eua is achieved and product proven) could be worth billions (assuming gov contracts etc). SE1 is currently trading below likely sales value for our part if Nanodx goes ahead. If Nanodx testing solution goes main stream it would make a lot of sense to take out suppliers like SE1 early. All IMO.
SE1 Price at posting:
3.9¢ Sentiment: Buy Disclosure: Held
